Early detection of cancer and CHD via GE interaction approach

Cancer and Coronary Heart Disease (CHD) are the major health problems all over the world. The main obstacle facing cancer and CHD prevention is a lack of precise approach for early detection and prevention of these diseases. Most previous works on these diseases dealt with only infected patients. New technique under accurate statistical experimental design must be developed in order to early detect and diagnose of these diseases. Therefore, genotype-environment interaction, which indicates the different responsiveness of various genotypes to different environment (drugs) can play an important issues to be cosidered by pathologists, pharmacists and molecular geneticists in ivestigating, detection, diagnosing and treating diseases.

Autorentext

Rafal Al-Rawi obtuvo el título de M. B. Ch. B. en 1999. Obtuvo el F.I.C.PATH en 2006. Es profesor adjunto de la Universidad Médica de Hawler, Kurdistán, Irak. Ha publicado 22 artículos científicos. Sus áreas de investigación son: diagnóstico clínico, histopatología y biomarcadores moleculares. Recientemente, su interés se centra en la patología molecular.